וואלהמשרד הבריאות מזהיר: כדורי ההרזיה G-Slim מכילים חומר תרופתי אסור RTP DesportoJoão Almeida nos convocados para os Mundiais de ciclismo de estrada Punch2027: Reps deputy spokesman backs Tinubu with new mobilisation group The Jerusalem PostDenis Mukin sentenced to 22 years for murder of Diar Omari in road dispute Inquirer EntertainmentLOOK: Empress Schuck expecting baby girl InquirerFilipino historian named honorary professor in Mexico Daily MaverickCoalition likely in Philippines’ Muslim south with no clear winner in election ColliderPrincess Donut Officially Gets Her Own ‘Dungeon Crawler Carl’ Release South China Morning PostWho will shoulder the debts behind Indonesia’s China-backed Whoosh railway?Sky TG24Legge elettorale, Calenda: "Perpetua scontro nel Paese"Deadline‘We Will Dance Again’ Exec Joins Israel’s Yoav Gross Productions To Run Content Straits Times SportBit of luck to go a long way for All About Al

Seeking Alpha·United States·Tuesday, September 15, 2026 at 08:05 AM

Ascendis Pharma sets $400M stock buyback plan

Translate

Preeti Singh

Ascendis Pharma (ASND) board has authorized the company to repurchase up to $400M of its ordinary shares.
The program does not require the company to repurchase any specific number of shares, and may be modified, suspended, or terminated at any time without notice.

View the original on Seeking Alpha →

KioskNews shows a cleaned-up reading view extracted from the publisher’s page — the original always lives on their site, not ours.